A detailed history of Telemus Capital, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Telemus Capital, LLC holds 20,157 shares of JNJ stock, worth $2.93 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
20,157
Previous 20,053 0.52%
Holding current value
$2.93 Million
Previous $3.12 Million 1.15%
% of portfolio
0.26%
Previous 0.29%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024

BUY
$145.6 - $158.88 $15,142 - $16,523
104 Added 0.52%
20,157 $3.16 Million
Q3 2023

Oct 25, 2023

SELL
$155.75 - $174.48 $9,656 - $10,817
-62 Reduced 0.31%
20,053 $3.12 Million
Q2 2023

Jul 10, 2023

SELL
$154.35 - $166.11 $363,339 - $391,022
-2,354 Reduced 10.48%
20,115 $3.33 Million
Q1 2023

Apr 11, 2023

BUY
$151.05 - $180.26 $387,141 - $462,006
2,563 Added 12.88%
22,469 $3.48 Million
Q4 2022

Jan 11, 2023

SELL
$160.2 - $179.79 $651,052 - $730,666
-4,064 Reduced 16.95%
19,906 $0
Q3 2022

Oct 11, 2022

BUY
$161.33 - $179.52 $14,681 - $16,336
91 Added 0.38%
23,970 $3.92 Million
Q2 2022

Aug 10, 2022

SELL
$168.19 - $186.01 $103,268 - $114,210
-614 Reduced 2.51%
23,879 $4.24 Million
Q1 2022

Apr 06, 2022

BUY
$158.14 - $179.59 $412,903 - $468,909
2,611 Added 11.93%
24,493 $4.34 Million
Q4 2021

Feb 01, 2022

SELL
$155.93 - $173.01 $47,246 - $52,422
-303 Reduced 1.37%
21,882 $3.74 Million
Q3 2021

Oct 27, 2021

BUY
$161.5 - $179.47 $150,356 - $167,086
931 Added 4.38%
22,185 $3.58 Million
Q2 2021

Aug 09, 2021

SELL
$159.48 - $171.07 $1.5 Million - $1.61 Million
-9,423 Reduced 30.72%
21,254 $3.5 Million
Q1 2021

Apr 20, 2021

BUY
$153.07 - $170.48 $162,560 - $181,049
1,062 Added 3.59%
30,677 $5.01 Million
Q4 2020

Jan 28, 2021

BUY
$137.11 - $157.38 $15,767 - $18,098
115 Added 0.39%
29,615 $4.66 Million
Q3 2020

Nov 02, 2020

SELL
$140.38 - $153.83 $65,978 - $72,300
-470 Reduced 1.57%
29,500 $4.37 Million
Q2 2020

Jul 17, 2020

BUY
$128.81 - $155.51 $142,721 - $172,305
1,108 Added 3.84%
29,970 $4.27 Million
Q1 2020

Jun 05, 2020

BUY
$111.14 - $153.99 $704,627 - $976,296
6,340 Added 28.15%
28,862 $4.29 Million
Q4 2019

Jan 24, 2020

SELL
$127.5 - $146.44 $741,412 - $851,548
-5,815 Reduced 20.52%
22,522 $3.29 Million
Q3 2019

Nov 12, 2019

BUY
$126.95 - $142.14 $141,549 - $158,486
1,115 Added 4.1%
28,337 $3.67 Million
Q2 2019

Aug 09, 2019

SELL
$131.15 - $144.24 $781,654 - $859,670
-5,960 Reduced 17.96%
27,222 $3.54 Million
Q1 2019

May 02, 2019

SELL
$125.72 - $139.79 $60,219 - $66,959
-479 Reduced 1.42%
33,182 $4.64 Million
Q4 2018

Feb 06, 2019

BUY
$122.84 - $147.84 $57,734 - $69,484
470 Added 1.42%
33,661 $4.34 Million
Q3 2018

Oct 23, 2018

BUY
$121.58 - $142.88 $102,735 - $120,733
845 Added 2.61%
33,191 $4.59 Million
Q2 2018

Jul 31, 2018

BUY
$119.4 - $131.76 $39,402 - $43,480
330 Added 1.03%
32,346 $3.93 Million
Q1 2018

Apr 27, 2018

SELL
$125.1 - $148.14 $30,149 - $35,701
-241 Reduced 0.75%
32,016 $4.1 Million
Q4 2017

Feb 02, 2018

BUY
$131.22 - $143.62 $1.04 Million - $1.13 Million
7,893 Added 32.4%
32,257 $4.51 Million
Q3 2017

Nov 03, 2017

SELL
$129.47 - $135.38 $437,090 - $457,042
-3,376 Reduced 12.17%
24,364 $3.17 Million
Q2 2017

Apr 03, 2018

SELL
N/A
-1,882 Reduced 6.35%
27,740 $3.67 Million
Q1 2017

Apr 03, 2018

BUY
N/A
29,622
29,622 $3.69 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Telemus Capital, LLC Portfolio

Follow Telemus Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemus Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Telemus Capital, LLC with notifications on news.